News & Updates

Most men with a history of anabolic steroid use have severe oligospermia, with only a few of them achieving normal semen parameters after 6 months of treatment, according to a study.

Development of eosinophilic esophagitis (EoE) is associated with prenatal, intrapartum, and neonatal factors, particularly preterm birth and admission to neonatal intensive care unit (NICU), suggests a study.

The FDA-approved intrauterine vacuum-induced haemorrhage-control device rapidly controls bleeding in both vaginal and caesarean births, with a safety profile consistent with that observed in the registrational trial, as shown in a postmarket registry medical record review study.

New mothers who are struggling to fall or stay asleep may find relief from therapist-assisted cognitive behavioural therapy (CBT) and light dark therapy (LDT), which have been shown to be safe and effective at reducing postpartum insomnia symptoms.

New drug applications approved by US FDA as of 01-15 September 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Treating postnatal depression with selective serotonin reuptake inhibitors (SSRIs) may be beneficial for both mothers and their children in the long term, with a recent study showing that SSRIs can reduce the risk of several negative outcomes, such as maternal depression and child behavioural problems, according to a study.